The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
The Economic Impact of a Bioterrorist Attack: Are Prevention and Postattack Intervention Programs Justifiable?
Open accessAbstract
Understanding and quantifying the impact of a bioterrorist attack are essential in developing public health preparedness for such an attack. We constructed a model that compares the impact of three classic agents of biologic warfare (Bacillus anthracis, Brucella melitensis, and Francisella tularensis) when released as aerosols in the suburb of a major city. The model shows that the economic impact of a bioterrorist attack can range from an estimated $477.7 million per 100,000 persons exposed (brucellosis scenario) to $26.2 billion per 100,000 persons exposed (anthrax scenario). Rapid implementation of a postattack prophylaxis program is the single most important means of reducing these losses. By using an insurance analogy, our model provides economic justification for preparedness measures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Abstract of the United States
(2005) · Encyclopedia of Statistical Sciences · doi:10.1002/0471667196.ess2527 · Cited by 8,785
The Sverdlovsk Anthrax Outbreak of 1979
Meselson, M., Guillemin, J., Hugh-Jones, M., Langmuir, A., Popova, I., Shelokov, A., & Yampolskaya, O. (1994) · Science · doi:10.1126/science.7973702 · Cited by 1,006
Prevention effectiveness : a guide to decision analysis and economic evaluation
Haddix, A. C. (1996) · Cited by 576
Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979.
Abramova, F. A., Grinberg, L. M., Yampolskaya, O. V., & Walker, D. H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.6.2291 · Cited by 410
Postexposure Prophylaxis against Experimental Inhalation Anthrax
Friedlander, A. M., Welkos, S. L., Pitt, M. L. M., Ezzell, J. W., Worsham, P. L., Rose, K. J., Ivins, B. E., Lowe, J. R., Howe, G. B., Mikesell, P., et al. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/167.5.1239 · Cited by 406
Tularemia Vaccine Study: II. Respiratory Challenge
SASLAW, S. (1961) · Archives of Internal Medicine · doi:10.1001/archinte.1961.03620050068007 · Cited by 400
Feldman, J. J., Kleinman, J. C., Makuc, D. M., Mościcki, E. K., Pierre, M. B., & Wagener, D. K. (1989) · Cited by 397
Estimating Costs in Cost Effectiveness Analysis
Luce, B. R., Manning, W. G., Siegel, J. E., & Lipscomb, J. (1996) · doi:10.1093/oso/9780195108248.003.0006 · Cited by 229
Lipscomb, J., Weinstein, M. C., & Torrance, G. W. (1996) · doi:10.1093/oso/9780195108248.003.0007 · Cited by 115
Cited by
Anthrax as a Biological Weapon: Medical and Public Health Management
Inglesby, T. V., Henderson, D. A., Bartlett, J. G., Ascher, M. S., Eitzen, E., Friedlander, A. M., Hauer, J., McDade, J., Osterholm, M. T., O'Toole, T., et al. (1999) · JAMA · doi:10.1001/jama.281.18.1735 · Cited by 892
Transmissibility of 1918 pandemic influenza
Mills, C. E., Robins, J. M., & Lipsitch, M. (2004) · Nature · doi:10.1038/nature03063 · Cited by 796
Tularemia: History, Epidemiology, Pathogen Physiology, and Clinical Manifestations
SJÖSTEDT, A. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1409.009 · Cited by 593
by, P., Bower, W. A., Hendricks, K., Pillai, S., Guarnizo, J., & Meaney-Delman, D. (2015) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6404a1 · Cited by 585
The political economy of terrorism
(2006) · Choice Reviews Online · doi:10.5860/choice.43-5994 · Cited by 462
Metadata
- Venue
- Emerging Infectious Diseases
- Published
- 1997-06
- Volume
- 3
- Issue
- 2
- Pages
- 83-94
- ISSN
- 1080-6040 (ISSN-L)
- 1080-6059
- OpenAlex
- W2103989683
- Cited by
- 465
- References
- 9
- FWCI
- 18.86
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.